These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1329294)

  • 1. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine.
    Moskowitz MA
    Trends Pharmacol Sci; 1992 Aug; 13(8):307-11. PubMed ID: 1329294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and experimental effects of sumatriptan in humans.
    Ferrari MD; Saxena PR
    Trends Pharmacol Sci; 1993 Apr; 14(4):129-33. PubMed ID: 8390743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurogenic vs vascular mechanisms of sumatriptan and ergot alkaloids in migraine.
    Edvinsson L
    Cephalalgia; 1998 Jan; 18(1):5. PubMed ID: 9601617
    [No Abstract]   [Full Text] [Related]  

  • 5. Sumatriptan.
    Bateman DN
    Lancet; 1993 Jan; 341(8839):221-4. PubMed ID: 8093509
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurogenic inflammation in the pathophysiology and treatment of migraine.
    Moskowitz MA
    Neurology; 1993 Jun; 43(6 Suppl 3):S16-20. PubMed ID: 8389008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
    Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On serotonin and migraine: a clinical and pharmacological review.
    Ferrari MD; Saxena PR
    Cephalalgia; 1993 Jun; 13(3):151-65. PubMed ID: 8395342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan: efficacy and contribution to migraine mechanisms.
    Pearce JM
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries.
    Hamel E; Fan E; Linville D; Ting V; Villemure JG; Chia LS
    Mol Pharmacol; 1993 Aug; 44(2):242-6. PubMed ID: 8394988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan: new relief for migraine headaches.
    Holdcroft C
    Nurse Pract; 1993 Jul; 18(7):11, 14. PubMed ID: 8394559
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of antimigraine drugs.
    Saxena PR; Den Boer MO
    J Neurol; 1991; 238 Suppl 1():S28-35. PubMed ID: 1646288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sumatriptan on visual aura symptoms in migraine.
    Schoenen J
    Headache; 1993 Mar; 33(3):164. PubMed ID: 8387475
    [No Abstract]   [Full Text] [Related]  

  • 15. Sumatriptan: a new serotonin agonist for the treatment of migraine headache.
    Susman JL
    Am Fam Physician; 1993 Feb; 47(3):645-7. PubMed ID: 8382004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects and mechanism of action of sumatriptan in migraine.
    Ferrari MD; Saxena PR
    Clin Neurol Neurosurg; 1992; 94 Suppl():S73-7. PubMed ID: 1320526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sumatriptan and its use in treatment of migraine and cluster headaches].
    Prusiński A
    Neurol Neurochir Pol; 1992; Suppl 2():28-48. PubMed ID: 1337766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT(1)-like receptor agonists and the pathophysiology of migraine.
    Saxena PR; Ferrari MD
    Trends Pharmacol Sci; 1989 May; 10(5):200-4. PubMed ID: 12722735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan: a selective 5-hydroxytryptamine receptor agonist for the acute treatment of migraine.
    Fullerton T; Gengo FM
    Ann Pharmacother; 1992 Jun; 26(6):800-8. PubMed ID: 1319244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From serotonin receptor classification to the antimigraine drug sumatriptan.
    Saxena PR; Ferrari MD
    Cephalalgia; 1992 Aug; 12(4):187-96. PubMed ID: 1326401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.